Michael Brandon Baule, DO
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: 059546 · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Baule’s office at (408) 340-5700 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 88.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$73,772
Medicare paid this office $73,772 for 358 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 210 | $32,440 | $113 |
| Short return visit (20+ min) | 124 | $10,943 | $81 |
| New patient visit (45+ min) | 40 | $5,911 | $148 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,309 | $154 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 203 | $4,143 | $14 |
See all 11 services
| Return visit (30+ min) | 210 | $32,440 | $113 |
| Short return visit (20+ min) | 124 | $10,943 | $81 |
| New patient visit (45+ min) | 40 | $5,911 | $148 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,309 | $154 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 203 | $4,143 | $14 |
| Long return visit (40+ min) | 18 | $3,164 | $151 |
| New patient visit (30+ min) | 28 | $2,514 | $90 |
| Sarscov2 vac 50 mcg/0.5ml im | 16 | $2,458 | $154 |
| Influenza vaccine split virus, preservative free | 17 | $1,391 | $82 |
| Admn sarscov2 vacc 1 dose | 16 | $834 | $52 |
| Administration of influenza virus vaccine | 18 | $688 | $38 |
Who their Medicare patients are
358 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 15% · Women 47% · Also on Medicaid 9% · Health risk score 1.07. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68% · Coronary heart disease 28% · Diabetes 25% · Chronic kidney disease 19% · Atrial fibrillation 18% · Cancer 16% · Heart failure 15% · Depression 13% · COPD 11% · Stroke 8% · Dementia 6%.
The office billed $278,774, Medicare allowed $96,525 and paid $73,772; for 968 services of 34 kinds; $5,918 of it was for drugs given in the office and $67,853 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 358 | 968 | 75 | 1.07 | $278,774 | $73,772 |
| 2022 | 426 | 9,309 | 73 | 1.14 | $244,297 | $74,886 |
| 2021 | 860 | 8,904 | 73 | 1.18 | $278,658 | $96,124 |
| 2020 | 345 | 10,805 | 71 | 1.28 | $156,188 | $48,862 |
| 2019 | 308 | 9,483 | 70 | 1.23 | $173,164 | $63,550 |
| 2018 | 321 | 704 | 72 | 1.45 | $123,872 | $38,322 |
| 2017 | 159 | 262 | 71 | 1.58 | $42,766 | $15,544 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 19 services
| Return visit (30+ min) | 159 | $18,197 | $85 |
| Influenza vaccine split virus, preservative free | 91 | $6,293 | $68 |
| Short return visit (20+ min) | 90 | $5,630 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,797 | $131 |
| Adm sarscv2 bvl 30mcg/.3ml a | 81 | $3,150 | $39 |
| Long return visit (40+ min) | 21 | $3,025 | $137 |
| Administration of influenza virus vaccine | 99 | $2,934 | $29 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, tris-sucrose formulation; booster dose | 62 | $2,472 | $39 |
| Blood test, lipids (cholesterol and triglycerides) | 58 | $780 | $13 |
| Blood test, comprehensive group of blood chemicals | 68 | $771 | $10 |
| Injection of drug or substance under skin or into muscle | 17 | $531 | $11 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 15 | $523 | $35 |
| Administration of pneumococcal vaccine | 13 | $415 | $30 |
| Hemoglobin a1c level | 34 | $394 | $10 |
| Insertion of needle into vein for collection of blood sample | 52 | $178 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 20 | $162 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 13 | $126 | $8 |
| Measurement c-reactive protein for detection of infection or inflammation | 13 | $67 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 14 | $57 | $4 |
2021: 23 services
| Return visit (30+ min) | 163 | $21,396 | $88 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | 269 | $10,751 | $40 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; booster dose | 191 | $7,642 | $40 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 304 | $6,321 | $21 |
| Short return visit (20+ min) | 83 | $6,039 | $65 |
| Influenza vaccine split virus, preservative free | 62 | $4,107 | $65 |
| Long return visit (40+ min) | 29 | $4,007 | $118 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; third dose | 65 | $2,601 | $40 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,464 | $133 |
| Administration of influenza virus vaccine | 68 | $1,174 | $17 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 11 | $941 | $45 |
| Blood test, comprehensive group of blood chemicals | 62 | $803 | $11 |
| Blood test, lipids (cholesterol and triglycerides) | 50 | $777 | $13 |
| Injection of drug or substance under skin or into muscle | 14 | $431 | $10 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 12 | $424 | $35 |
| Hemoglobin a1c level | 31 | $418 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $308 | $21 |
| Insertion of needle into vein for collection of blood sample | 65 | $249 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 27 | $218 | $8 |
| Blood test, basic group of blood chemicals (calcium, total) | 18 | $178 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 27 | $121 | $4 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 12 | $78 | $6 |
| Manual urinalysis test with examination using microscope, automated | 14 | $44 | $3 |
2020: 10 services
| Return visit (30+ min) | 92 | $10,217 | $68 |
| Influenza vaccine split virus, preservative free | 124 | $7,555 | $61 |
| Short return visit (20+ min) | 74 | $4,818 | $50 |
| Administration of influenza virus vaccine | 132 | $2,220 | $17 |
| Injection of drug or substance under skin or into muscle | 21 | $613 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $609 | $22 |
| Blood test, lipids (cholesterol and triglycerides) | 13 | $174 | $13 |
| Blood test, comprehensive group of blood chemicals | 15 | $158 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 17 | $95 | $6 |
| Insertion of needle into vein for collection of blood sample | 13 | $39 | $3 |
2019: 13 services
| Return visit (30+ min) | 102 | $12,361 | $80 |
| Short return visit (20+ min) | 71 | $4,895 | $56 |
| Influenza vaccine split virus, preservative free | 80 | $4,391 | $55 |
| Administration of influenza virus vaccine | 88 | $1,450 | $16 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 14 | $903 | $38 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 11 | $704 | $50 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $656 | $18 |
| Injection of drug or substance under skin or into muscle | 21 | $652 | $13 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 12 | $586 | $25 |
| Administration of pneumococcal vaccine | 11 | $181 | $16 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $160 | $15 |
| Insertion of needle into vein for collection of blood sample | 21 | $68 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 11 | $61 | $6 |
2018: 11 services
| Short return visit (20+ min) | 121 | $7,260 | $35 |
| Return visit (30+ min) | 86 | $6,522 | $52 |
| Initial hospital observation care per day, typically 50 minutes | 52 | $5,039 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $3,289 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $2,819 | $97 |
| Hospital observation care on day of discharge | 44 | $2,621 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,659 | $128 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,596 | $84 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,079 | $57 |
| Follow-up observation care per day, typically 25 minutes | 15 | $929 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 35 | $199 | $6 |
2017: 6 services
| Return visit (30+ min) | 50 | $3,463 | $60 |
| Short return visit (20+ min) | 56 | $2,674 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,290 | $81 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,260 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $950 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $105 | $7 |
Medicaid work
$36,190 in 2022
Medicaid paid $36,190 for 461 billed services this clinician did in 2022, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 263 | $25,167 |
| Short return visit (20+ min) | 159 | $10,717 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $239 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $68 |
| Severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, tris-sucrose formulation, for intramuscular use | 13 | $0 |
| 2022 | 461 | 5 | 35 | $36,190 |
| 2021 | 755 | 8 | 31 | $43,219 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 282 | $25,228 |
| Short return visit (20+ min) | 237 | $15,170 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 46 | $1,213 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 18 | $577 |
| SARSCOV CORONAVIRUS AG IA | 17 | $515 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 20 | $451 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 16 | $65 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use | 119 | $0 |
Drugs they prescribed that Part D paid
$87,200
Pharmacies billed $87,200 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (37 of 1,377) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,252 generic and fewer than 11 brand-name prescriptions · $87,200 in drug cost · 50 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 20 | $21,368 | $1,068 |
| Xarelto | 11 | $7,042 | $640 |
| Albuterol Sulfate Hfa | 23 | $1,228 | $53 |
| Atorvastatin | 84 | $1,079 | $13 |
| Levothyroxine | 63 | $904 | $14 |
See all 36 drugs
| Jardiance | 20 | $21,368 | $1,068 |
| Xarelto | 11 | $7,042 | $640 |
| Albuterol Sulfate Hfa | 23 | $1,228 | $53 |
| Atorvastatin | 84 | $1,079 | $13 |
| Levothyroxine | 63 | $904 | $14 |
| Celecoxib | 45 | $904 | $20 |
| Tamsulosin | 44 | $831 | $19 |
| Metoprolol | 33 | $798 | $24 |
| Lisinopril | 40 | $533 | $13 |
| Amlodipine Besylate | 44 | $476 | $11 |
| Losartan | 36 | $458 | $13 |
| Gabapentin | 26 | $412 | $16 |
| Rosuvastatin | 41 | $360 | $9 |
| Omeprazole | 26 | $339 | $13 |
| Hydrocodone-Acetaminophen | 19 | $326 | $17 |
| Pravastatin | 13 | $277 | $21 |
| Metformin | 20 | $263 | $13 |
| Fluticasone Propionate | 22 | $254 | $12 |
| Fluoxetine | 17 | $223 | $13 |
| Lisinopril-Hydrochlorothiazide | 20 | $219 | $11 |
| Metformin Hcl Er | 24 | $210 | $9 |
| Simvastatin | 18 | $194 | $11 |
| Losartan-Hydrochlorothiazide | 15 | $164 | $11 |
| Sertraline | 11 | $163 | $15 |
| Escitalopram | 13 | $152 | $12 |
| Trazodone | 18 | $149 | $8 |
| Alendronate | 18 | $139 | $8 |
| Furosemide | 16 | $133 | $8 |
| Metoprolol | 13 | $131 | $10 |
| Atenolol | 11 | $124 | $11 |
| Carvedilol | 12 | $105 | $9 |
| Allopurinol | 12 | $74 | $6 |
| Hydrocortisone | 12 | $68 | $6 |
| Alprazolam | 14 | $62 | $4 |
| Prednisone | 14 | $59 | $4 |
| Lorazepam | 13 | $50 | $4 |
Year by year
| 2024 | 1,377 | 373 | 3% (37) | None | $87,200 |
| 2023 | 1,590 | 328 | 1% (19) | None | $145,658 |
| 2022 | 3,754 | 418 | 2% (71) | 10% | $317,744 |
| 2021 | 3,210 | 353 | 2% (71) | 11% | $234,151 |
| 2020 | 2,885 | 266 | 3% (71) | 10% | $176,851 |
| 2019 | 2,079 | 314 | 4% (87) | 11% | $99,800 |
| 2018 | 2,017 | 227 | 3% (58) | None | $109,908 |
| 2017 | 518 | 130 | 6% (30) | None | $27,798 |
| 2016 | 209 | 56 | 6% (12) | None | $13,396 |
| 2015 | 80 | 30 | None | 20% | $7,388 |
| 2014 | 21 | None | None | None | $262 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Eliquis | 22 | $20,206 | $918 |
| Xarelto | 17 | $17,737 | $1,043 |
| Symbicort | 17 | $5,903 | $347 |
| Atorvastatin | 86 | $1,345 | $16 |
| Tamsulosin | 42 | $1,144 | $27 |
| Metoprolol | 44 | $1,085 | $25 |
| Levothyroxine | 63 | $983 | $16 |
| Lisinopril | 75 | $902 | $12 |
| Rosuvastatin | 24 | $632 | $26 |
| Amlodipine Besylate | 54 | $590 | $11 |
| Pantoprazole | 39 | $566 | $15 |
| Albuterol Sulfate Hfa | 18 | $515 | $29 |
| Simvastatin | 42 | $499 | $12 |
| Celecoxib | 21 | $489 | $23 |
| Losartan | 41 | $439 | $11 |
| Gabapentin | 21 | $390 | $19 |
| Omeprazole | 26 | $366 | $14 |
| Glipizide Er | 14 | $333 | $24 |
| Montelukast | 19 | $316 | $17 |
| Lisinopril-Hydrochlorothiazide | 24 | $314 | $13 |
| Fluticasone Propionate | 13 | $275 | $21 |
| Metformin | 30 | $272 | $9 |
| Metoprolol | 35 | $269 | $8 |
| Potassium Chloride | 11 | $247 | $22 |
| Hydrochlorothiazide | 36 | $246 | $7 |
| Furosemide | 36 | $244 | $7 |
| Carvedilol | 19 | $236 | $12 |
| Mirtazapine | 13 | $229 | $18 |
| Trazodone | 21 | $225 | $11 |
| Terbinafine | 13 | $224 | $17 |
| Sertraline | 11 | $221 | $20 |
| Losartan-Hydrochlorothiazide | 11 | $198 | $18 |
| Atenolol | 14 | $131 | $9 |
| Hydrocodone-Acetaminophen | 11 | $131 | $12 |
| Escitalopram | 14 | $125 | $9 |
| Citalopram Hbr | 12 | $123 | $10 |
| Metformin Hcl Er | 13 | $119 | $9 |
| Meloxicam | 15 | $94 | $6 |
2022: 71 drugs
| Eliquis | 66 | $62,562 | $948 |
| Xarelto | 15 | $23,772 | $1,585 |
| Januvia | 23 | $20,645 | $898 |
| Lantus Solostar | 26 | $16,833 | $647 |
| Jardiance | 13 | $13,376 | $1,029 |
| Symbicort | 24 | $11,897 | $496 |
| Humalog Kwikpen U-100 | 16 | $10,547 | $659 |
| Celecoxib | 48 | $4,123 | $86 |
| Metoprolol | 138 | $3,677 | $27 |
| Atorvastatin | 220 | $3,345 | $15 |
| Ventolin Hfa | 30 | $2,651 | $88 |
| Gabapentin | 73 | $2,614 | $36 |
| Tamsulosin | 98 | $2,541 | $26 |
| Lisinopril | 244 | $2,490 | $10 |
| Rosuvastatin | 64 | $1,998 | $31 |
| Duloxetine | 29 | $1,808 | $62 |
| Omeprazole | 86 | $1,649 | $19 |
| Albuterol Sulfate Hfa | 29 | $1,531 | $53 |
| Memantine Hcl Er | 11 | $1,355 | $123 |
| Simvastatin | 132 | $1,323 | $10 |
| Pantoprazole | 79 | $1,280 | $16 |
| Losartan | 84 | $1,157 | $14 |
| Amlodipine Besylate | 124 | $1,134 | $9 |
| Fluticasone Propionate | 35 | $1,129 | $32 |
| Montelukast | 51 | $1,124 | $22 |
| Bupropion Xl | 19 | $1,059 | $56 |
| Metformin | 106 | $882 | $8 |
| Levetiracetam | 17 | $865 | $51 |
| Doxazosin Mesylate | 34 | $808 | $24 |
| Sertraline | 53 | $691 | $13 |
| Glipizide Er | 34 | $623 | $18 |
| Carvedilol | 63 | $613 | $10 |
| Trazodone | 64 | $588 | $9 |
| Allopurinol | 29 | $531 | $18 |
| Levothyroxine | 42 | $528 | $13 |
| Gemfibrozil | 22 | $486 | $22 |
| Metoprolol | 66 | $486 | $7 |
| Warfarin | 49 | $464 | $9 |
| Hydralazine | 17 | $435 | $26 |
| Prednisone | 44 | $435 | $10 |
| Propranolol | 12 | $432 | $36 |
| Pravastatin | 28 | $426 | $15 |
| Hydrochlorothiazide | 82 | $399 | $5 |
| Metformin Hcl Er | 50 | $396 | $8 |
| Donepezil | 21 | $382 | $18 |
| Lisinopril-Hydrochlorothiazide | 37 | $370 | $10 |
| Clopidogrel | 30 | $355 | $12 |
| Buspirone | 15 | $354 | $24 |
| Hydrocodone-Acetaminophen | 28 | $327 | $12 |
| Furosemide | 78 | $319 | $4 |
| Potassium Chloride | 21 | $253 | $12 |
| Jantoven | 15 | $247 | $16 |
| Torsemide | 11 | $223 | $20 |
| Escitalopram | 14 | $209 | $15 |
| Finasteride | 19 | $208 | $11 |
| Spironolactone | 16 | $188 | $12 |
| Citalopram Hbr | 17 | $185 | $11 |
| Atenolol | 29 | $182 | $6 |
| Lovastatin | 11 | $182 | $17 |
| Verapamil Er | 12 | $181 | $15 |
| Lorazepam | 19 | $165 | $9 |
| Tizanidine | 19 | $136 | $7 |
| Cyclobenzaprine | 14 | $125 | $9 |
| Famotidine | 16 | $106 | $7 |
| Meloxicam | 12 | $102 | $8 |
| Cephalexin | 16 | $86 | $5 |
| Triamcinolone Acetonide | 14 | $81 | $6 |
| Tramadol | 33 | $79 | $2 |
| Azithromycin | 13 | $71 | $5 |
| Fluoxetine | 14 | $70 | $5 |
| Alprazolam | 15 | $26 | $2 |
2021: 62 drugs
| Eliquis | 30 | $27,752 | $925 |
| Xarelto | 23 | $26,457 | $1,150 |
| Januvia | 30 | $19,400 | $647 |
| Symbicort | 32 | $17,509 | $547 |
| Lantus Solostar | 22 | $14,957 | $680 |
| Novolog Flexpen | 11 | $6,334 | $576 |
| Gabapentin | 99 | $2,825 | $29 |
| Ventolin Hfa | 37 | $2,520 | $68 |
| Metoprolol | 90 | $2,277 | $25 |
| Atorvastatin | 166 | $2,238 | $13 |
| Lisinopril | 185 | $2,008 | $11 |
| Tamsulosin | 73 | $1,902 | $26 |
| Rosuvastatin | 50 | $1,657 | $33 |
| Omeprazole | 89 | $1,158 | $13 |
| Albuterol Sulfate Hfa | 24 | $1,128 | $47 |
| Celecoxib | 24 | $1,115 | $46 |
| Losartan | 83 | $1,099 | $13 |
| Montelukast | 57 | $1,052 | $18 |
| Duloxetine | 28 | $1,046 | $37 |
| Simvastatin | 112 | $1,008 | $9 |
| Amlodipine Besylate | 126 | $914 | $7 |
| Fluticasone Propionate | 35 | $834 | $24 |
| Sertraline | 56 | $806 | $14 |
| Metformin | 89 | $784 | $9 |
| Glipizide Er | 29 | $750 | $26 |
| Gemfibrozil | 22 | $746 | $34 |
| Levothyroxine | 53 | $722 | $14 |
| Doxazosin Mesylate | 34 | $677 | $20 |
| Allopurinol | 28 | $548 | $20 |
| Warfarin | 48 | $524 | $11 |
| Bupropion Xl | 14 | $493 | $35 |
| Carvedilol | 51 | $470 | $9 |
| Pantoprazole | 45 | $448 | $10 |
| Metoprolol | 64 | $448 | $7 |
| Lisinopril-Hydrochlorothiazide | 37 | $427 | $12 |
| Trazodone | 52 | $420 | $8 |
| Propranolol | 13 | $400 | $31 |
| Hydrochlorothiazide | 73 | $366 | $5 |
| Escitalopram | 27 | $355 | $13 |
| Prednisone | 48 | $299 | $6 |
| Buspirone | 13 | $297 | $23 |
| Pravastatin | 12 | $286 | $24 |
| Jantoven | 17 | $260 | $15 |
| Metformin Hcl Er | 23 | $257 | $11 |
| Hydrocodone-Acetaminophen | 20 | $256 | $13 |
| Tizanidine | 27 | $246 | $9 |
| Torsemide | 11 | $233 | $21 |
| Clonazepam | 14 | $228 | $16 |
| Spironolactone | 15 | $200 | $13 |
| Furosemide | 61 | $191 | $3 |
| Lovastatin | 14 | $191 | $14 |
| Doxycycline Hyclate | 19 | $188 | $10 |
| Hydralazine | 23 | $183 | $8 |
| Citalopram Hbr | 17 | $176 | $10 |
| Meloxicam | 15 | $163 | $11 |
| Methylprednisolone | 16 | $155 | $10 |
| Triamcinolone Acetonide | 13 | $134 | $10 |
| Atenolol | 19 | $132 | $7 |
| Tramadol | 42 | $127 | $3 |
| Clopidogrel | 12 | $110 | $9 |
| Glipizide | 12 | $78 | $6 |
| Cephalexin | 18 | $67 | $4 |
2020: 64 drugs
| Eliquis | 25 | $20,474 | $819 |
| Xarelto | 17 | $18,359 | $1,080 |
| Lantus Solostar | 27 | $15,546 | $576 |
| Januvia | 21 | $13,938 | $664 |
| Symbicort | 19 | $10,569 | $556 |
| Levemir Flextouch | 11 | $5,424 | $493 |
| Metoprolol | 90 | $2,555 | $28 |
| Ventolin Hfa | 33 | $2,343 | $71 |
| Atorvastatin | 167 | $2,282 | $14 |
| Gabapentin | 58 | $1,800 | $31 |
| Celecoxib | 51 | $1,691 | $33 |
| Duloxetine | 31 | $1,508 | $49 |
| Lisinopril | 159 | $1,261 | $8 |
| Rosuvastatin | 31 | $1,088 | $35 |
| Tamsulosin | 53 | $1,058 | $20 |
| Alcohol Pads | 19 | $1,013 | $53 |
| Montelukast | 57 | $973 | $17 |
| Levothyroxine | 31 | $837 | $27 |
| Losartan | 75 | $825 | $11 |
| Simvastatin | 110 | $775 | $7 |
| Omeprazole | 74 | $774 | $10 |
| Verapamil Er | 14 | $763 | $55 |
| Warfarin | 50 | $718 | $14 |
| Fluticasone Propionate | 23 | $704 | $31 |
| Amlodipine Besylate | 135 | $651 | $5 |
| Allopurinol | 31 | $598 | $19 |
| Sertraline | 39 | $566 | $15 |
| Memantine Hcl Er | 20 | $563 | $28 |
| Doxazosin Mesylate | 19 | $546 | $29 |
| Pregabalin | 11 | $510 | $46 |
| Metformin | 70 | $495 | $7 |
| Trazodone | 50 | $458 | $9 |
| Escitalopram | 36 | $435 | $12 |
| Carvedilol | 45 | $410 | $9 |
| Gemfibrozil | 15 | $409 | $27 |
| Bupropion Xl | 13 | $378 | $29 |
| Glipizide Er | 19 | $377 | $20 |
| Prednisone | 36 | $349 | $10 |
| Atenolol | 23 | $345 | $15 |
| Pravastatin | 11 | $344 | $31 |
| Metoprolol | 54 | $334 | $6 |
| Hydrochlorothiazide | 71 | $330 | $5 |
| Furosemide | 65 | $323 | $5 |
| Paroxetine | 21 | $283 | $13 |
| Pantoprazole | 43 | $277 | $6 |
| Lisinopril-Hydrochlorothiazide | 27 | $276 | $10 |
| Hydralazine | 29 | $273 | $9 |
| Cyclobenzaprine | 16 | $253 | $16 |
| Enalapril Maleate | 11 | $248 | $23 |
| Jantoven | 14 | $223 | $16 |
| Doxycycline Hyclate | 12 | $222 | $19 |
| Donepezil | 29 | $203 | $7 |
| Triamcinolone Acetonide | 15 | $199 | $13 |
| Risperidone | 11 | $191 | $17 |
| Meloxicam | 23 | $187 | $8 |
| Tizanidine | 21 | $182 | $9 |
| Lovastatin | 13 | $137 | $11 |
| Timolol Maleate | 12 | $127 | $11 |
| Citalopram Hbr | 12 | $110 | $9 |
| Hydrocodone-Acetaminophen | 19 | $108 | $6 |
| Tramadol | 40 | $102 | $3 |
| Metformin Hcl Er | 11 | $87 | $8 |
| Glipizide | 13 | $78 | $6 |
| Quetiapine | 21 | $74 | $4 |
2019: 55 drugs
| Januvia | 15 | $7,278 | $485 |
| Levemir Flextouch | 11 | $5,061 | $460 |
| Lyrica | 12 | $3,200 | $267 |
| Ventolin Hfa | 13 | $2,148 | $165 |
| Basaglar Kwikpen U-100 | 12 | $1,879 | $157 |
| Metoprolol | 47 | $1,551 | $33 |
| Alcohol Pads | 26 | $1,424 | $55 |
| Atorvastatin | 77 | $1,354 | $18 |
| Rosuvastatin | 16 | $977 | $61 |
| Celecoxib | 33 | $750 | $23 |
| Lisinopril | 87 | $715 | $8 |
| Levothyroxine | 38 | $683 | $18 |
| Omeprazole | 69 | $632 | $9 |
| Gabapentin | 39 | $568 | $15 |
| Bupropion Xl | 19 | $535 | $28 |
| Tamsulosin | 39 | $475 | $12 |
| Metformin | 52 | $472 | $9 |
| Montelukast | 33 | $459 | $14 |
| Warfarin | 31 | $453 | $15 |
| Simvastatin | 56 | $435 | $8 |
| Diltiazem 24hr Er (Cd) | 22 | $395 | $18 |
| Amlodipine Besylate | 70 | $382 | $5 |
| Venlafaxine Hcl Er | 18 | $374 | $21 |
| Venlafaxine | 16 | $363 | $23 |
| Diclofenac | 14 | $318 | $23 |
| Pravastatin | 19 | $310 | $16 |
| Ondansetron Odt | 14 | $306 | $22 |
| Losartan | 36 | $301 | $8 |
| Doxazosin Mesylate | 16 | $299 | $19 |
| Allopurinol | 25 | $295 | $12 |
| Hydrocodone-Acetaminophen | 32 | $292 | $9 |
| Carvedilol | 29 | $270 | $9 |
| Sertraline | 32 | $252 | $8 |
| Potassium Chloride | 16 | $245 | $15 |
| Ketoconazole | 11 | $234 | $21 |
| Hydralazine | 23 | $231 | $10 |
| Furosemide | 48 | $222 | $5 |
| Pantoprazole | 24 | $215 | $9 |
| Ranitidine | 28 | $214 | $8 |
| Fluticasone Propionate | 12 | $207 | $17 |
| Amitriptyline | 16 | $207 | $13 |
| Meloxicam | 37 | $206 | $6 |
| Cyclobenzaprine | 19 | $199 | $10 |
| Levetiracetam | 11 | $193 | $18 |
| Zolpidem | 14 | $182 | $13 |
| Metoprolol | 26 | $173 | $7 |
| Hydrochlorothiazide | 26 | $171 | $7 |
| Tizanidine | 18 | $168 | $9 |
| Trazodone | 18 | $157 | $9 |
| Donepezil | 20 | $155 | $8 |
| Fluoxetine | 13 | $153 | $12 |
| Tramadol | 32 | $149 | $5 |
| Lisinopril-Hydrochlorothiazide | 16 | $146 | $9 |
| Baclofen | 14 | $133 | $9 |
| Prednisone | 20 | $118 | $6 |
2018: 59 drugs
| Eliquis | 24 | $12,372 | $515 |
| Januvia | 18 | $11,994 | $666 |
| Breo Ellipta | 12 | $6,659 | $555 |
| Levemir Flextouch | 12 | $5,208 | $434 |
| Potassium Chloride | 58 | $1,717 | $30 |
| Levothyroxine | 76 | $1,421 | $19 |
| Rosuvastatin | 19 | $1,378 | $73 |
| Trospium Chloride | 12 | $1,046 | $87 |
| Methylphenidate | 15 | $881 | $59 |
| Atorvastatin | 48 | $808 | $17 |
| Pravastatin | 28 | $623 | $22 |
| Omeprazole | 99 | $613 | $6 |
| Warfarin | 60 | $604 | $10 |
| Amitriptyline | 31 | $534 | $17 |
| Sucralfate | 18 | $463 | $26 |
| Carbamazepine | 14 | $463 | $33 |
| Metoprolol | 24 | $460 | $19 |
| Celecoxib | 11 | $399 | $36 |
| Tamsulosin | 24 | $383 | $16 |
| Duloxetine | 12 | $378 | $32 |
| Oxybutynin Chloride | 11 | $343 | $31 |
| Trazodone | 12 | $303 | $25 |
| Amlodipine Besylate | 80 | $294 | $4 |
| Lisinopril | 51 | $288 | $6 |
| Donepezil | 27 | $277 | $10 |
| Allopurinol | 15 | $248 | $17 |
| Metformin | 37 | $240 | $6 |
| Venlafaxine Hcl Er | 14 | $238 | $17 |
| Ranitidine | 26 | $237 | $9 |
| Memantine | 11 | $216 | $20 |
| Diltiazem 24hr Er (Cd) | 11 | $214 | $19 |
| Tramadol | 29 | $213 | $7 |
| Furosemide | 53 | $204 | $4 |
| Montelukast | 30 | $200 | $7 |
| Sertraline | 33 | $196 | $6 |
| Pramipexole Dihydrochloride | 21 | $185 | $9 |
| Finasteride | 15 | $176 | $12 |
| Fluticasone Propionate | 13 | $159 | $12 |
| Baclofen | 12 | $157 | $13 |
| Metformin Hcl Er | 22 | $156 | $7 |
| Metoprolol | 25 | $154 | $6 |
| Prednisone | 25 | $147 | $6 |
| Losartan | 25 | $146 | $6 |
| Triamterene-Hydrochlorothiazid | 20 | $142 | $7 |
| Hydrocodone-Acetaminophen | 13 | $133 | $10 |
| Lorazepam | 23 | $126 | $5 |
| Tizanidine | 14 | $121 | $9 |
| Pantoprazole | 13 | $120 | $9 |
| Citalopram Hbr | 16 | $113 | $7 |
| Clopidogrel | 18 | $110 | $6 |
| Carvedilol | 13 | $101 | $8 |
| Indapamide | 11 | $99 | $9 |
| Simvastatin | 22 | $90 | $4 |
| Meloxicam | 18 | $88 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $84 | $7 |
| Glipizide | 15 | $75 | $5 |
| Cyclobenzaprine | 16 | $70 | $4 |
| Clonazepam | 22 | $67 | $3 |
| Nortriptyline | 11 | $65 | $6 |
2017: 10 drugs
| Levothyroxine | 25 | $494 | $20 |
| Gabapentin | 14 | $316 | $23 |
| Allopurinol | 11 | $191 | $17 |
| Omeprazole | 20 | $188 | $9 |
| Atorvastatin | 13 | $174 | $13 |
| Tramadol | 18 | $169 | $9 |
| Trazodone | 11 | $148 | $13 |
| Pantoprazole | 11 | $96 | $9 |
| Amlodipine Besylate | 15 | $59 | $4 |
| Meloxicam | 11 | $35 | $3 |
2016: 2 drugs
| Omeprazole | 13 | $94 | $7 |
| Metformin | 11 | $25 | $2 |
Money from drug and device companies
$19 in 2022
| 2022 | 1 | 1 | None | $19 |
| 2021 | 1 | 1 | None | $12 |
| 2019 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Corium | Adlarity | $19 | 1 payment
|
See the published payment
| Corium | Meals · 2022-11-01 | Adlarity | $19 |
See earlier years (2021, 2019)
2021: $12
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $12 | 1 payment
|
2019: $15
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $15 | 1 payment
|
Professional record
- NPI
- 1073928586
- Licence
- NE 7280
- Trained
- Des Moines University of Osteopathic Medicine and Health Sciences, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 15425 Los Gatos Blvd Ste 120, Los Gatos, CA, 95032
- NPI first listed
- 2014-06-23
- NPI last updated
- 2024-06-11
- NPI record certified
- 2024-06-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 15425 Los Gatos Blvd Ste 120, Los Gatos, CA, 95032 · 983075 Nebraska Medical Ctr, Omaha, NE, 68198
This office lists an electronic records connection.